Distal Ischemic Stroke Treatment with Adjustable Low-profile Stentriever

Brief description of study

Stroke is a condition where the blood flow to the brain is blocked, potentially resulting in lack of oxygen, brain damage and loss of function. It is most often caused by a clot in a blood vessel supplying blood to the brain. It can also be caused by bleeding when a burst vessel causes blood to flow into the brain.

The currently available treatment options for acute ischemic stroke focus on restoring the blood flow to the affected area as quickly as possible. This is done either by administering a drug that dissolves the clot and/or by use of a device inserted into the brain by inserting a catheter through the skin into a blood vessel to restore blood flow. However, subjects who are eligible for clot-dissolving drugs are not eligible to participate in this study. Removal of a clot by a device is dependent on the location of the clot, the size of the blood vessel, and the ability of the device to safely access and retrieve the clot.

Rapid Medical has developed the Tigertriever 13, a device to remove the blood clot in small, distal blood vessels and restore blood flow to the brain.

The purpose of this study is to evaluate the safety and effectiveness of the treatment with the investigational Tigertriever 13 device as compared to standard medical management.




If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.